Small packages: UI nanotechnology firm gets $2 million boost in fight against cancer

By: Katharine Carlon|May 17, 2021

Coralville-based NanoMedTrix is using nanoparticles to deliver chemotherapy drugs directly to cancerous growths. The tiny particles also include a contrast agent to allow tumors to be visualized, as in this 3D virtual cystoscopy.

A novel technology that delivers anti-cancer drugs via nanoparticles to tumors – and helps physicians monitor them in real time — has won a University of Iowa spin-out a $2 million Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to help the company find a partner in the pharmaceutical world.

NanoMedTrix, founded by Jose Assouline, an adjunct associate professor in the Roy J. Carver Department…

Want to Read More?

Get immediate, unlimited access to all subscriber content and much more.

Learn more in our subscriber FAQ.

Subscribe

OR

Login

Unparalleled business coverage of the Iowa City / Cedar Rapids corridor.Immediate access to subscriber-only content on our website.26 issues per year delivered digitally, in print or both.Support locally owned and operated journalism.

Do you want to read and share this article without a paywall?

Click here to purchase a paywall bypass link

Small packages: UI nanotechnology firm gets $2 million boost in fight against cancer

Want to Read More?

YOU MIGHT ALSO LIKE